Korean Drug Co Ltd

014570

Company Profile

  • Business description

    Korean Drug Co Ltd is engaged in the business of manufacture and sale of pharmaceuticals. Its products include comprehensive cold remedies, hematopoietic nutrients, central nervous system agents, digestive system agents, dermatological agents, vitamins/nutritional supplements, antibiotics, antibacterials, antipyretics, analgesics, and anti-inflammatory agents. The group manufacture and sell over-the-counter medications, including Haben, Korea's cold remedy, as well as prescription drugs for various conditions, including central nervous system (CNS) diseases such as dementia, epilepsy, stroke, and Parkinson's disease.

  • Contact

    69-10 Wonjeok-ro
    Sindun-myeon
    Gyeonggi-do
    Icheon-si
    KOR

    T: +82 316347100

    https://www.nicepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    240

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,390.1016.400.17%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,426.9923.420.25%
HKSE26,027.55168.720.65%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,316.06130.560.27%
NZX 50 Index13,324.0253.83-0.40%
S&P 5006,735.350.220.00%
S&P/ASX 2009,094.7018.800.21%
SSE Composite Index3,916.3352.441.36%

Market Movers